Showing 1,381 - 1,400 results of 108,886 for search '(( 1 point decrease ) OR ( 5 ((step decrease) OR (((we decrease) OR (a decrease)))) ))', query time: 2.36s Refine Results
  1. 1381

    Tacrolimus Decreases Albuminuria in Patients with IgA Nephropathy and Normal Blood Pressure: A Double-Blind Randomized Controlled Trial of Efficacy of Tacrolimus on IgA Nephropathy by Yong-Chul Kim (1637572)

    Published 2013
    “…We randomly assigned patients either to receive tacrolimus or placebo with stratification by using a renin angiotensin system blocker. …”
  2. 1382
  3. 1383
  4. 1384
  5. 1385
  6. 1386
  7. 1387
  8. 1388

    A Yoga Strengthening Program Designed to Minimize the Knee Adduction Moment for Women with Knee Osteoarthritis: A Proof-Of-Principle Cohort Study by Elora C. Brenneman (795723)

    Published 2015
    “…A secondary objective was to determine whether the program could improve mobility and fitness, and decrease peak KAM during gait. …”
  9. 1389
  10. 1390

    Taurolidine lock solution for catheter-related bloodstream infections in pediatric patients: A meta-analysis by Yan Sun (22436)

    Published 2020
    “…The number of catheters removed due to infection or suspected infection was not significantly different between the two groups (RR: 0.68; 95% CI:0.22, 2.10; I<sup>2</sup> = 56%; P = 0.50) (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0231110#pone.0231110.g005" target="_blank">Fig 5</a>). …”
  11. 1391
  12. 1392

    <i>SLC2A2</i> is essential for liver differentiation in developing vertebrates by Yejin Kim (740789)

    Published 2025
    “…Total RNA was isolated from uninjected control and <i>SLC2A2</i> MO‐injected embryos (2.5, 5, and 10 ng). …”
  13. 1393
  14. 1394
  15. 1395
  16. 1396
  17. 1397
  18. 1398
  19. 1399
  20. 1400

    The distribution of variables in PCR+ participants with detectable antibodies grouped as decreased, unchanged, increased, and antibody level ≥ 10 at time point T1 and T2. by Marjut Sarjomaa (13229272)

    Published 2022
    “…<p>The distribution of variables in PCR+ participants with detectable antibodies grouped as decreased, unchanged, increased, and antibody level ≥ 10 at time point T1 and T2.…”